person · Reporting owner
Epstein Jeffrey Douglas
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RRE Ventures Acquisition Corp.RREV · Entity 5843 | Director · President | March 02, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RRE Ventures Acquisition Corp.
Report date March 02, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Ordinary SharesSEC Table II · derivative / convertible security | Direct | 450,000 |
Reported balance
After 2026-03-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 450,000 · Balance 450,000 F1: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F2: These securities were previously reported on a Form 3 filed by the Reporting Person. |
| Class B Ordinary SharesSEC Table II · derivative / convertible security | Direct | 600,000 |
Reported balance
After 2026-03-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-18 · Grant · Acquired 150,000 · Balance 600,000 F1: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F2: These securities were previously reported on a Form 3 filed by the Reporting Person. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 500,000 |
Reported balance
After 2026-05-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-01 · Grant · Acquired 500,000 · Balance 500,000 F3: The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation. |
Filing footnotes · ownership attribution and instrument terms
F1: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
F2: These securities were previously reported on a Form 3 filed by the Reporting Person.
F3: The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 5, 2026 20:30 UTC | RRE Ventures Acquisition Corp. RREV · Entity 5843 | GrantWarrant · Derivative | 500,000 | $1.00 Strike: $11.50 | $500,000.00 |
DisclosureSEC source: 0001193125-26-206544 · ownership.xml · derivative · entry 3 Epstein Jeffrey Douglas · CIK 0002130441 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Ordinary Shares · 500,000 shares Expires not disclosed F3 · derivative.exercise_date: The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation. F3 · derivative.expiration_date: The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation. Read SEC document |
| March 18, 2026 Filed May 5, 2026 20:30 UTC | RRE Ventures Acquisition Corp. RREV · Entity 5843 | GrantClass B Ordinary Shares · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-206544 · ownership.xml · derivative · entry 2 Epstein Jeffrey Douglas · CIK 0002130441 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Class A Ordinary Shares · 150,000 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F1 · derivative.exercise_date: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F1 · derivative.expiration_date: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F2 · balance_after: These securities were previously reported on a Form 3 filed by the Reporting Person. Read SEC document |
| March 02, 2026 Filed May 5, 2026 20:30 UTC | RRE Ventures Acquisition Corp. RREV · Entity 5843 | GrantClass B Ordinary Shares · Derivative | 450,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-206544 · ownership.xml · derivative · entry 1 Epstein Jeffrey Douglas · CIK 0002130441 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Class A Ordinary Shares · 450,000 shares Expires not disclosed F1 · derivative.exercise_price: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F1 · derivative.exercise_date: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F1 · derivative.expiration_date: The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. F2 · balance_after: These securities were previously reported on a Form 3 filed by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.